Current Infectious Disease Reports

, Volume 8, Issue 4, pp 265–270 | Cite as

Changing epidemiology of infective endocarditis

Article

Abstract

Infective endocarditis (IE) continues to be a serious infection with a stable incidence rate over time and a persistently high mortality. Population-based studies from France, Netherlands, Sweden, and the United States reported on the epidemiology of this infection. These studies suggest a changing distribution of underlying valvular heart disease in patients with IE, namely a decreasing proportion of patients with rheumatic heart disease and an increasing proportion with underlying prosthetic valves or mitral valve prolapse. There is controversy regarding the change of spectrum of IE-causative organisms. In some geographically defined populations with complete case ascertainment, viridans group streptococci continue to be the most common causative organisms, whereas in passively reported community surveys and in referral-center case series, Staphylococcus aureus is surpassing streptococci as the leading cause for IE.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Osler W: The Goulstonian lectures on malignant endocarditis. BMJ 1885, 1:467–470.CrossRefGoogle Scholar
  2. 2.
    Moreillon P, Que YA: Infective endocarditis. Lancet 2004, 363:139–149.PubMedCrossRefGoogle Scholar
  3. 3.
    Steckelberg JM, Melton LJ III, Ilstrup DM, et al.: Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990, 88:582–588. This study illustrates the impact of referral bias on the apparent characteristics of IE. The authors compared characteristics of IE cases from Olmsted County, MN, to those referred for treatment to the Mayo Clinic.PubMedCrossRefGoogle Scholar
  4. 4.
    Delahaye F, Goulet V, Lacassin F, et al.: Characteristics of infective endocarditis in France in 1991: a 1-year survey. Eur Heart J 1995, 16:394–401.PubMedGoogle Scholar
  5. 5.
    Hoen B, Alla F, Selton-Suty C, et al.: Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75–81. This is a large population-based survey conducted in 1999 in all hospitals of six French regions (16 million inhabitants). Results of this survey are compared with an earlier survey in 1991.PubMedCrossRefGoogle Scholar
  6. 6.
    van der Meer JT, Thompson J, Valkenburg HA, Michel MF: Epidemiology of bacterial endocarditis in the Netherlands, I: patient characteristics. Arch Intern Med 1992, 152:1863–1868. This is a nationwide survey conducted from 1986 to 1988 in the Netherlands. The authors describe the epidemiology of IE in their population.PubMedCrossRefGoogle Scholar
  7. 7.
    Hogevik H, Olaison L, Andersson R, et al.: Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 1995, 74:324–339. This is a population-based study that describes IE characteristics in Goteborg, Sweden, over a 5-year period (1984-1988).CrossRefGoogle Scholar
  8. 8.
    Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022–3028. This is a recent study that examined temporal trends in IE characteristics in a population-based setting in the United States. The authors describe the incidence and characteristics of IE cases in Olmsted County, MN, and examine for temporal trends over the period of 1970 to 2000.PubMedCrossRefGoogle Scholar
  9. 9.
    Fowler VG, Miro JM, Hoen B, et al.: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012–3021. This study reports on data from a large prospective cohort of the International Collaboration on Endocarditis (ICE), which enrolled 1779 patients in 39 centers in 16 countries between 2000 and 2003. This study describes the contemporary spectrum of IE characteristics as seen at referral institutions.PubMedCrossRefGoogle Scholar
  10. 10.
    Wisplinghoff H, Bischoff T, Tallent SM, et al.: Nosocomial bloodstream infections in US hospitals. Clin Infect Dis 2004, 39:309–317.PubMedCrossRefGoogle Scholar
  11. 11.
    Roder BL, Wandall DA, Frimodt-Moller N, et al.: Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999, 159:462–469. This study is an analysis of the clinical features of S. aureus endocarditis in a nationwide population of nondrug addicts in Denmark. It illustrates the paucity of clinical findings in patients with S. aureus endocarditis.PubMedCrossRefGoogle Scholar
  12. 12.
    Fowler VG Jr, Li J, Corey GR, et al.: Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997, 30:1072–1078.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Infectious DiseasesMayo Clinic College of Medicine, Mayo ClinicRochesterUSA

Personalised recommendations